Bacterial etiology and antibiotic susceptibility pattern of ventilator-associated pneumonia (VAP) in burn patients
Article Sidebar
Main Article Content
Abstract
This research aimed to identify the spectrum of microbial pathogens associated with VAP and the drug resistance patterns at an intensive care unit (ICU) burn center in Iran. We conducted this single-center, retrospective, cross-sectional descriptive study on all burn patients with VAP who were treated in the ICU at Velayat Burn Injuries Hospital in Rasht, northern Iran. In this study, 29 samples were obtained from burn patients, of which P. aeruginosa accounted for 48.3%, Klebsiella for 17.2%, E. coli for 10.3%, coagulase-negative Staphylococci for 6.9%, and unknown pathogens for 17.2% of the bacterial cultures. All the E. coli isolates and most of the Klebsiella isolates (80%) were obtained in the first two days of hospitalization. P. aeruginosa was mainly isolated during the first 2 days of hospitalization (71.4%). The mortality rate was 75.9%, while 24.1% of the patients were discharged. Antibiotic susceptibility patterns of Gram-negative bacteria revealed that Enterobacter and P. aeruginosa were predominantly susceptible to aminoglycosides, with Amikacin exhibiting the highest effective rates of 40% and 66.7%, respectively. A guideline-based approach using the local ICU antibiogram can decrease the likelihood of Multidrug-resistant (MDR) strain occurrence.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
[1] Li Y, Gong Z, Lu Y, Hu G, Cai R, Chen Z. Impact of nosocomial infections surveillance on nosocomial infection rates: A systematic review. Int J Surg. 2017;42:164-169.
DOI: 10.1016/j.ijsu.2017.04.065 PMID: 28476543
[2] Wang L, Zhou KH, Chen W, Yu Y, Feng SF. Epidemiology and risk factors for nosocomial infection in the respiratory intensive care unit of a teaching hospital in China: A prospective surveillance during 2013 and 2015. BMC Infect Dis. 2019;19(1):145. DOI: 10.1186/s12879-019-3772-2
PMID: 30755175
[3] Mortazavi M, Darvishi M, Markazi-Moghaddam Na, Balaye Sz. Epidemiology of nosocomial infections and related factors in patients admitted to the intensive care unit of selected hospitals in Tehran. Pakistan J Med Heal Sci. 2020;14(4):1396–400.
URL: https://pjmhsonline.com/2020/oct_dec/1396.pdf
[4] American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416. DOI: 10.1164/rccm.200405-644ST PMID: 15699079
[5] Keeley L. Reducing the risk of ventilator-acquired pneumonia through head of bed elevation. Nurs Crit Care. 2007;12(6):287-94. DOI: 10.1111/j.1478-5153.2007.00247.x PMID: 17983363
[6] Sanz Herrero F, Blanquer Olivas J. Microbiology and risk factors for community-acquired pneumonia. Semin Respir Crit Care Med. 2012;33(3):220-31. DOI: 10.1055/s-0032-1315634
PMID: 22718208
[7] Góralska K, Kurnatowski P. Parasites as etiological factors of nosocomial infections. Ann Parasitol. 2013;59(1):3-11.
PMID: 23829052
[8] Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198-208. DOI: 10.1056/NEJMoa1306801 PMID: 24670166
[9] Khilnani GC, Jain N. Ventilator-Associated Pneumonia: Changing microbiology and implications. Indian J Crit Care Med. 2013;17(6):331-2. DOI: 10.4103/0972-5229.123432
PMID: 24501481
[10] George DL, Falk PS, Wunderink RG, Leeper KV Jr, Meduri GU, Steere EL, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med. 1998;158(6):1839-47.
DOI: 10.1164/ajrccm.158.6.9610069 PMID: 9847276
[11] Erdem I, Ozgultekin A, Inan AS, Dincer E, Turan G, Ceran N, et al. Incidence, etiology, and antibiotic resistance patterns of gram-negative microorganisms isolated from patients with ventilator-associated pneumonia in a medical-surgical intensive care unit of a teaching hospital in istanbul, Turkey (2004-2006). Jpn J Infect Dis. 2008;61(5):339-42. PMID: 18806338
[12] Sierawska O, Małkowska P, Taskin C, Hrynkiewicz R, Mertowska P, Grywalska E, et al. Innate Immune System Response to Burn Damage-Focus on Cytokine Alteration. Int J Mol Sci. 2022;23(2):716. DOI: 10.3390/ijms23020716
PMID: 35054900
[13] Hosseini M, Hasannejad-Bibalan M, Yaghoubi T, Mobayen M, Khoshdoz P, Khoshdoz S, et al. Prevalence and Antibiotic Resistance Pattern of Gram-Positive Isolates from Burn Patients in Velayat Burn Center in Rasht, North of Iran. mljgoums 2021;15(6):52-57.
URL: https://pjmhsonline.com/2020/oct_dec/1396.pdf
[14] Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. 1998;113(2):412-20. DOI: 10.1378/chest.113.2.412 PMID: 9498961
[15] Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129(6):433-40. DOI: 10.7326/0003-4819-129-6-199809150-00002 PMID: 9735080
[16] Sen S, Johnston C, Greenhalgh D, Palmieri T. Ventilator-Associated Pneumonia Prevention Bundle Significantly Reduces the Risk of Ventilator-Associated Pneumonia in Critically Ill Burn Patients. J Burn Care Res. 2016;37(3):166-71.
DOI: 10.1097/BCR.0000000000000228 PMID: 25501774
[17] Zilberberg MD, Nathanson BH, Puzniak LA, Shorr AF. Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012-2019. Crit Care Med. 2022;50(3):460-468.
DOI: 10.1097/CCM.0000000000005298 PMID: 34534129
[18] Yesilbag Z, Seker YT. Epidemiology and the Risk Factors for Mortality in Ventilator-Associated Pneumonia. Medical Journal of Bakirkoy. 2020;16(3). DOI: 10.5222/BMJ.2020.43760
[19] Feng DY, Zhou YQ, Zhou M, Zou XL, Wang YH, Zhang TT. Risk Factors for Mortality Due to Ventilator-Associated Pneumonia in a Chinese Hospital: A Retrospective Study. Med Sci Monit. 2019;25:7660-7665. DOI: 10.12659/MSM.916356 PMID: 31605472
[20] Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903.
DOI: 10.1164/ajrccm.165.7.2105078 PMID: 11934711
[21] Huang Y, Jiao Y, Zhang J, Xu J, Cheng Q, Li Y, et al. Microbial Etiology and Prognostic Factors of Ventilator-associated Pneumonia: A Multicenter Retrospective Study in Shanghai. Clin Infect Dis. 2018;67(suppl_2):S146-S152.
DOI: 10.1093/cid/ciy686 PMID: 30423049
[22] Russo A, Olivadese V, Trecarichi EM, Torti C. Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic. J Clin Med. 2022;11(9):2279. DOI: 10.3390/jcm11092279 PMID: 35566405